Randomized Controlled Trial
doi: 10.7326/M18-1569.
Epub 2018 Dec 4.
Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial
Affiliations
- PMID: 30508430
- DOI: 10.7326/M18-1569
Item in Clipboard
Randomized Controlled Trial
Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial
Ann Intern Med.
.
No abstract available
Similar articles
-
[Possibilities of influencing cardiovascular risk in type 2 diabetes mellitus by antidiabetic treatment Lowering of cardiovascular risk in treatment with liraglutide - Results of the LEADER].Vnitr Lek. 2016 Fall;62(7-8):613-5. Vnitr Lek. 2016. PMID: 27627086 Review. Czech.
-
Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.Circulation. 2018 May 15;137(20):2179-2183. doi: 10.1161/CIRCULATIONAHA.118.033898. Circulation. 2018. PMID: 29760228 Clinical Trial. No abstract available.
-
Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial.Diabetes Obes Metab. 2017 Jun;19(6):901-905. doi: 10.1111/dom.12884. Epub 2017 Mar 2. Diabetes Obes Metab. 2017. PMID: 28105731 Clinical Trial.
-
[The antidiabetic drug liraglutide lowers risk of cardiac death].MMW Fortschr Med. 2016 Jun 23;158(12):14. doi: 10.1007/s15006-016-8410-y. MMW Fortschr Med. 2016. PMID: 27323977 Clinical Trial. German. No abstract available.
-
Novel Antidiabetic Therapies and Cardiovascular Risk Reduction: The Role of the Noninferiority Trial.Cardiol Clin. 2019 Aug;37(3):335-343. doi: 10.1016/j.ccl.2019.04.007. Epub 2019 May 8. Cardiol Clin. 2019. PMID: 31279427 Review.
Cited by
-
Long-Term Cardiovascular Outcomes of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes: A Systematic Review.Cureus. 2024 Nov 14;16(11):e73705. doi: 10.7759/cureus.73705. eCollection 2024 Nov. Cureus. 2024. PMID: 39568487 Free PMC article. Review.
-
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.Diabetes Ther. 2024 Nov 9. doi: 10.1007/s13300-024-01659-7. Online ahead of print. Diabetes Ther. 2024. PMID: 39520501
-
Pharmacological Treatment of Obesity in Older Adults.Drugs Aging. 2024 Nov;41(11):881-896. doi: 10.1007/s40266-024-01150-9. Epub 2024 Nov 8. Drugs Aging. 2024. PMID: 39514148 Free PMC article. Review.
-
Glucagon-like Peptide-1 Receptor Agonists in the Context of Pathophysiology of Diverse Heart Failure with Preserved Ejection Fraction Phenotypes: Potential Benefits and Mechanisms of Action.Card Fail Rev. 2024 Oct 16;10:e14. doi: 10.15420/cfr.2024.06. eCollection 2024. Card Fail Rev. 2024. PMID: 39507374 Free PMC article. Review.
-
Management of older adults with diabetes mellitus: Perspective from geriatric medicine.J Diabetes Investig. 2024 Oct;15(10):1347-1354. doi: 10.1111/jdi.14283. Epub 2024 Aug 8. J Diabetes Investig. 2024. PMID: 39115890 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
